CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 28 filers reported holding CLOVIS ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 49,064,000 | $44,037,000 | 1.28% |
| United Asset Strategies, Inc. | 1,955,000 | $1,758,000 | 0.35% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,992,000 | $1,773,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,664,000 | $2,398,000 | 0.08% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 2,170,000 | $1,953,000,000 | 0.04% |
| MACKAY SHIELDS LLC | 110,000 | $101,000 | 0.00% |
| UBS Group AG | 3,000 | $3,000 | 0.00% |
| NOMURA HOLDINGS INC | 68,267 | $5,000 | 0.00% |
| ROYAL BANK OF CANADA | 1,000 | $1,000 | 0.00% |
| FMR LLC | 1,728,000 | $1,556,000 | 0.00% |